Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA44375
Max Phase: Preclinical
Molecular Formula: C21H14O4
Molecular Weight: 330.34
Molecule Type: Small molecule
Associated Items:
ID: ALA44375
Max Phase: Preclinical
Molecular Formula: C21H14O4
Molecular Weight: 330.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(c1ccccc1)c1cc(O)c2c(c1)Cc1cccc(O)c1C2=O
Standard InChI: InChI=1S/C21H14O4/c22-16-8-4-7-13-9-14-10-15(20(24)12-5-2-1-3-6-12)11-17(23)19(14)21(25)18(13)16/h1-8,10-11,22-23H,9H2
Standard InChI Key: ZTZNKBVGHRNWCH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 330.34 | Molecular Weight (Monoisotopic): 330.0892 | AlogP: 3.46 | #Rotatable Bonds: 2 |
Polar Surface Area: 74.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.06 | CX Basic pKa: | CX LogP: 5.70 | CX LogD: 5.62 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.55 | Np Likeness Score: 0.71 |
1. Müller K, Leukel P, Ziereis K, Gawlik I.. (1994) Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition., 37 (11): [PMID:8201600] [10.1021/jm00037a017] |
Source(1):